Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations.

IF 4.7 3区 医学 Q1 ONCOLOGY JCO oncology practice Pub Date : 2024-09-01 Epub Date: 2024-04-29 DOI:10.1200/OP.23.00716
Nicolas H Hart, Larissa Nekhlyudov, Thomas J Smith, Jasmine Yee, Margaret I Fitch, Gregory B Crawford, Bogda Koczwara, Fredrick D Ashbury, Maryam B Lustberg, Michelle Mollica, Andrea L Smith, Michael Jefford, Fumiko Chino, Robin Zon, Meera R Agar, Raymond J Chan
{"title":"Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations.","authors":"Nicolas H Hart, Larissa Nekhlyudov, Thomas J Smith, Jasmine Yee, Margaret I Fitch, Gregory B Crawford, Bogda Koczwara, Fredrick D Ashbury, Maryam B Lustberg, Michelle Mollica, Andrea L Smith, Michael Jefford, Fumiko Chino, Robin Zon, Meera R Agar, Raymond J Chan","doi":"10.1200/OP.23.00716","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>People with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared with those with early-stage disease or those nearing the end of life. These Multinational Association for Supportive Care in Cancer (MASCC)-ASCO standards and practice recommendations seek to establish consistent provision of quality survivorship care for people affected by advanced or metastatic cancer.</p><p><strong>Methods: </strong>A MASCC-ASCO expert panel was formed. Standards and recommendations relevant to the provision of quality survivorship care for people affected by advanced or metastatic cancer were developed through conducting (1) a systematic review of unmet supportive care needs; (2) a scoping review of cancer survivorship, supportive care, and palliative care frameworks and guidelines; and (3) an international modified Delphi consensus process.</p><p><strong>Results: </strong>A systematic review involving 81 studies and a scoping review of 17 guidelines and frameworks informed the initial standards and recommendations. Subsequently, 77 experts (including eight people with lived experience) across 33 countries (33% were low- to middle-resource countries) participated in the Delphi study and achieved ≥94.8% agreement for seven standards, (1) Person-Centered Care; (2) Coordinated and Integrated Care; (3) Evidence-Based and Comprehensive Care; (4) Evaluated and Communicated Care; (5) Accessible and Equitable Care; (6) Sustainable and Resourced Care; and (7) Research and Data-Driven Care, and ≥84.2% agreement across 45 practice recommendations.</p><p><strong>Conclusion: </strong>Standards of survivorship care for people affected by advanced or metastatic cancer are provided. These MASCC-ASCO standards support optimization of health outcomes and care experiences by providing guidance to stakeholders (health care professionals, leaders, and administrators; governments and health ministries; policymakers; advocacy agencies; cancer survivors and caregivers). Practice recommendations may be used to facilitate future research, practice, policy, and advocacy efforts.Additional information is available at www.mascc.org, www.asco.org/standards and www.asco.org/survivorship-guidelines.</p>","PeriodicalId":14612,"journal":{"name":"JCO oncology practice","volume":null,"pages":null},"PeriodicalIF":4.7000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JCO oncology practice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1200/OP.23.00716","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: People with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared with those with early-stage disease or those nearing the end of life. These Multinational Association for Supportive Care in Cancer (MASCC)-ASCO standards and practice recommendations seek to establish consistent provision of quality survivorship care for people affected by advanced or metastatic cancer.

Methods: A MASCC-ASCO expert panel was formed. Standards and recommendations relevant to the provision of quality survivorship care for people affected by advanced or metastatic cancer were developed through conducting (1) a systematic review of unmet supportive care needs; (2) a scoping review of cancer survivorship, supportive care, and palliative care frameworks and guidelines; and (3) an international modified Delphi consensus process.

Results: A systematic review involving 81 studies and a scoping review of 17 guidelines and frameworks informed the initial standards and recommendations. Subsequently, 77 experts (including eight people with lived experience) across 33 countries (33% were low- to middle-resource countries) participated in the Delphi study and achieved ≥94.8% agreement for seven standards, (1) Person-Centered Care; (2) Coordinated and Integrated Care; (3) Evidence-Based and Comprehensive Care; (4) Evaluated and Communicated Care; (5) Accessible and Equitable Care; (6) Sustainable and Resourced Care; and (7) Research and Data-Driven Care, and ≥84.2% agreement across 45 practice recommendations.

Conclusion: Standards of survivorship care for people affected by advanced or metastatic cancer are provided. These MASCC-ASCO standards support optimization of health outcomes and care experiences by providing guidance to stakeholders (health care professionals, leaders, and administrators; governments and health ministries; policymakers; advocacy agencies; cancer survivors and caregivers). Practice recommendations may be used to facilitate future research, practice, policy, and advocacy efforts.Additional information is available at www.mascc.org, www.asco.org/standards and www.asco.org/survivorship-guidelines.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
晚期或转移性癌症患者的生存期护理:MASCC-ASCO 标准和实践建议》。
目的:晚期或转移性癌症患者及其护理者与早期疾病患者或临近生命终点的患者相比,可能有不同的护理目标,并面临独特的挑战。这些多国癌症支持性治疗协会(MASCC)-ASCO 标准和实践建议旨在为晚期或转移性癌症患者提供一致的优质生存期护理:方法:成立 MASCC-ASCO 专家小组。方法:成立了一个 MASCC-ASCO 专家小组,通过开展以下工作制定了为晚期或转移性癌症患者提供优质生存关怀的相关标准和建议:(1) 对未满足的支持性关怀需求进行系统回顾;(2) 对癌症生存关怀、支持性关怀以及姑息关怀框架和指南进行范围回顾;(3) 开展国际性的改良德尔菲共识程序:一项涉及 81 项研究的系统性综述和一项对 17 个指南和框架的范围界定综述为最初的标准和建议提供了依据。随后,33 个国家(33% 为中低端资源国家)的 77 位专家(包括 8 位有亲身经历者)参与了德尔菲研究,并就 7 项标准达成了≥94.8%,在45项实践建议中达成了≥84.2%的一致意见:结论:为晚期或转移性癌症患者提供了幸存者护理标准。这些 MASCC-ASCO 标准通过为利益相关者(医疗保健专业人员、领导者和管理者;政府和卫生部门;政策制定者;宣传机构;癌症幸存者和护理者)提供指导,支持优化健康结果和护理体验。实践建议可用于促进未来的研究、实践、政策和宣传工作。更多信息请访问 www.mascc.org、www.asco.org/standards 和 www.asco.org/survivorship-guidelines。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
6.40
自引率
7.50%
发文量
518
期刊最新文献
Why We Should, and How We Can, Reduce the Climate Toxicity of Cancer Care. Willingness of Women at Increased Risk of Breast Cancer to Participate in Prevention Trials. Telephone Survey-Reported Perceptions of Telehealth Visits Among Black and Non-Black Patients Diagnosed With Cancer. Effect of Prednisone Dosing on Mineralocorticoid-Related Side Effects With Abiraterone in Prostate Cancer. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is NOT a Last Resort: Rationale for Early Surgical Referral.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1